2022
When to Stop Screening—Liver Cancer
Taddei T, Jou J. When to Stop Screening—Liver Cancer. The American Journal Of Gastroenterology 2022, 118: 427-428. PMID: 36563304, DOI: 10.14309/ajg.0000000000002120.Peer-Reviewed Original ResearchClinical Research Training During Gastroenterology Fellowship
Saffo S, Taddei T. Clinical Research Training During Gastroenterology Fellowship. Digestive Diseases And Sciences 2022, 67: 1097-1100. PMID: 35113277, PMCID: PMC8983466, DOI: 10.1007/s10620-022-07407-w.Peer-Reviewed Original ResearchClinical CompetenceCurriculumFellowships and ScholarshipsGastroenterologyHumansSurveys and Questionnaires
2019
Introducing Palliative Care within the Treatment of End-Stage Liver Disease: The Study Protocol of a Cluster Randomized Controlled Trial
Verma M, Kosinski AS, Volk ML, Taddei T, Ramchandran K, Bakitas M, Green K, Green L, Navarro V. Introducing Palliative Care within the Treatment of End-Stage Liver Disease: The Study Protocol of a Cluster Randomized Controlled Trial. Journal Of Palliative Medicine 2019, 22: s-34-s-43. PMID: 31486722, DOI: 10.1089/jpm.2019.0121.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overEnd Stage Liver DiseaseFemaleHumansLongitudinal StudiesMaleMiddle AgedPalliative CareRandomized Controlled Trials as TopicSurveys and QuestionnairesConceptsEnd-stage liver diseaseQuality of lifePalliative careESLD patientsLiver diseaseMulticenter cluster-randomized trialPatients' QOLPatient-caregiver dyadsRoutine outpatient careComparative effectiveness trialHealth care utilizationGoal-concordant careCluster-randomized trialUnit of randomizationPrinciples of PCEligible patientsPC interventionsNew onsetAcute episodeSecondary outcomesSymptom burdenConcordant carePrimary outcomeCare utilizationCaregiver burden